Related references
Note: Only part of the references are listed.Radioiodine Ablation of Postsurgical Thyroid Remnants After Treatment With Recombinant Human TSH (rhTSH) in Patients With Moderate-to-Severe Graves' Orbitopathy (GO): A Prospective, Randomized, Single-Bind Clinical Trial
Mariacarla Moleti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Commentary: Rituximab, Adalimumab, Etanercept, Tocilizumab-Are Biologics the Future for Graves' Orbitopathy?
Luigi Bartalena
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Treatment of Active Corticosteroid-Resistant Graves' Orbitopathy
Jose Vicente Perez-Moreiras et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Adalimumab as Steroid-Sparing Treatment of Inflammatory-Stage Thyroid Eye Disease
Reed Ayabe et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2014)
Pretibial Myxedema Without Ophthalmopathy: An Initial Presentation of Graves' Disease
Sheela Lohiya et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2013)
Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005
Helena Filipsson Nystrom et al.
CLINICAL ENDOCRINOLOGY (2013)
Cutting Edge: Retrobulbar Inflammation, Adipogenesis, and Acute Orbital Congestion in a Preclinical Female Mouse Model of Graves' Orbitopathy Induced by Thyrotropin Receptor Plasmid-in Vivo Electroporation
Sajad Moshkelgosha et al.
ENDOCRINOLOGY (2013)
Insulin-like growth factor 1 promotes the proliferation and adipogenesis of orbital adipose-derived stromal cells in thyroid-associated ophthalmopathy
Pingqian Zhao et al.
EXPERIMENTAL EYE RESEARCH (2013)
Is IGF-I Receptor a Target for Autoantibody Generation in Graves' Disease?
Terry J. Smith
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Prevalence and Natural History of Graves' Orbitopathy in a Large Series of Patients With Newly Diagnosed Graves' Hyperthyroidism Seen at a Single Center
M. L. Tanda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
A Small Molecule Antagonist Inhibits Thyrotropin Receptor Antibody-Induced Orbital Fibroblast Functions Involved in the Pathogenesis of Graves Ophthalmopathy
Adina F. Turcu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Potential Utility of Rituximab for Graves' Orbitopathy
Mario Salvi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Diagnosis and management of Graves disease: a global overview
Luigi Bartalena
NATURE REVIEWS ENDOCRINOLOGY (2013)
Cohort Study on Radioactive Iodine-Induced Hypothyroidism: Implications for Graves' Ophthalmopathy and Optimal Timing for Thyroid Hormone Assessment
Marius N. Stan et al.
THYROID (2013)
Treatment of Pretibial Myxedema with Dexamethazone Injected Subcutaneously by Mesotherapy Needles
Guia Vannucchi et al.
THYROID (2013)
Graves' Orbitopathy: Imperfect Treatments for a Rare Disease
Luigi Bartalena
EUROPEAN THYROID JOURNAL (2013)
Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis
Christopher Heyes et al.
AUSTRALASIAN JOURNAL OF DERMATOLOGY (2012)
Role of insulin-like growth factor-1 (IGF-1) pathway in the pathogenesis of Graves' orbitopathy
Terry J. Smith et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Surgical treatment of Graves' ophthalmopathy
Anja Eckstein et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Immunopathogenesis of Graves' ophthalmopathy: The role of the TSH receptor
Seethalakshmi Iyer et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Thyroid dermopathy and acropachy
Vahab Fatourechi
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Prevention of Graves' ophthalmopathy
Luigi Bartalena
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Efficacy and Safety of Orbital Radiotherapy for Graves' Orbitopathy
Maria Laura Tanda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial
Marenza Leo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Efficacy and Safety of Three Different Cumulative Doses of Intravenous Methylprednisolone for Moderate to Severe and Active Graves' Orbitopathy
L. Bartalena et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study
Annamaria De Bellis et al.
ENDOCRINE (2012)
Observing pretibial myxedema in patients with Graves' disease using digital infrared thermal imaging and high-resolution ultrasonography: for better records, early detection, and further investigation
Shyang-Rong Shih et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Quality of life in thyroid eye disease: impact of quality of care
Stephanie Estcourt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
The Dilemma of How to Manage Graves' Hyperthyroidism in Patients with Associated Orbitopathy
Luigi Bartalena
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Intravenous Glucocorticoids for Graves' Orbitopathy: Efficacy and Morbidity
S. Zang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Autoimmunity in Graves' Ophthalmopathy: The Result of an Unfortunate Marriage Between TSH Receptors and IGF-1 Receptors?
Wilmar M. Wiersinga
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Dose of intravenous steroids and therapy outcome in Graves' orbitopathy
S. Zang et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2011)
Selenium and the Course of Mild Graves' Orbitopathy
Claudio Marcocci et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Multipoint Subcutaneous Injection of Long-Acting Glucocorticid as a Cure for Pretibial Myxedema
Aimin Deng et al.
THYROID (2011)
Atypical presentation of infiltrative thyroid dermopathy
S. A. Rice et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2010)
Treatment of Pretibial Myxedema (PTM) with Topical Steroid Ointment Application with Sealing Cover (Steroid Occlusive Dressing Technique: Steroid ODT) in Graves' Patients
Nobuyuki Takasu et al.
INTERNAL MEDICINE (2010)
Lower Dose Prednisone Prevents Radioiodine-Associated Exacerbation of Initially Mild or Absent Graves' Orbitopathy: A Retrospective Cohort Study
Adriana Lai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Pathogenesis of Graves' orbitopathy: A 2010 update
T. J. Smith
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2010)
MECHANISMS OF DISEASE Graves' Ophthalmopathy
Rebecca S. Bahn
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Risk Factors for Development or Deterioration of Graves' Ophthalmopathy
Marius N. Stan et al.
THYROID (2010)
The patient experience of services for thyroid eye disease in the United Kingdom: results of a nationwide survey
Stephanie Estcourt et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
Graves' Ophthalmopathy
Luigi Bartalena et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Imatinib Mesylate and AMN107 Inhibit PDGF-Signaling in Orbital Fibroblasts: A Potential Treatment for Graves' Ophthalmopathy
Leendert van Steensel et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2009)
Environmental tobacco smoke exposure and eye disease
N. Lois et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2008)
TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study
Peter Laurberg et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO
Luigi Bartalena et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Effects of total thyroid ablation versus near-total thyroidectomy alone on mild to moderate Graves' orbitopathy treated with intravenous glucocorticoids
Francesca Menconi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Determinants of liver damage associated with intravenous methylprednisolone pulse therapy in Graves' ophthalmopathy
Rosario Le Moli et al.
THYROID (2007)
Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link
T. J. Cawood et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
VISA classification for Graves orbitopathy
Peter J. Dolman et al.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers
W. M. Wiersinga et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
The effect of etanercept on Graves' ophthalmopathy: a pilot study
D Paridaens et al.
EYE (2005)
Psychosocial morbidity of Graves' orbitopathy
GJ Kahaly et al.
CLINICAL ENDOCRINOLOGY (2005)
Psychological disturbance in Graves ophthalmopathy
M Farid et al.
ARCHIVES OF OPHTHALMOLOGY (2005)
Pretibial myxedema - Pathophysiology and treatment options
V Fatourechi
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2005)
Relationship between cigarette smoking and Graves' ophthalmopathy
L Hegedüs et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)
Graves' dermopathy and acropachy are markers of severe Graves' ophthalmopathy
V Fatourechi et al.
THYROID (2003)
Thyroid acropachy: Report of 40 patients treated at a single institution in a 26-year period
V Fatourechi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Elephantiasic pretibial myxedema: A novel treatment for an uncommon disorder
WS Susser et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2002)
Elephantiasic pretibial myxedema: Insight into and a hypothesis regarding the pathogenesis of the extrathyroidal manifestations of Graves' disease
B Rapoport et al.
THYROID (2000)
Share Paper
